CYTOKI PHARMA
Cytoki Pharma is a biotechnology company that specializes in developing novel medicines for diseases with a significant unmet medical need with a focus on serious diseases caused by epithelial injury. CytoKi Pharma is a pre-clinical biotechnology company with focus on serious diseases caused by epithelial injury having an unmet medical need. Cytoki’s lead program is an engineered long-acting IL-22 protein licensed from a major pharmaceutical company.A correctly functioning immune system is ess... ential for keeping us healthy in the multitude of challenges our organism encounters. Numerous medicines are based on principles that activate or deactivate key proteins in the immune system in a disease context. IL-22 is a key cytokine (a class of proteins released from immune cells) in securing the survival and repair after an injury. It is the immune system’s “Survive and Recover” signal to the tissue. Our lead program is harnessing the power of IL-22, in treatment of organ injuries, through a modified IL-22 protein engineered to have optimal pharmaceutical properties.
CYTOKI PHARMA
Social Links:
Industry:
Biotechnology Life Science
Founded:
2019-01-01
Address:
Værløse, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.cytokipharma.com
Total Employee:
1+
Status:
Active
Total Funding:
45 M USD
Technology used in webpage:
Microsoft Exchange Online Person Schema Facebook Sharer Gravatar Profiles
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Lytica Therapeutics
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Seventure Partners
Seventure Partners investment in Series A - Cytoki Pharma
Lundbeckfonden Emerge
Lundbeckfonden Emerge investment in Series A - Cytoki Pharma
+ND Capital
+ND Capital investment in Series A - Cytoki Pharma
Ysios Capital
Ysios Capital investment in Series A - Cytoki Pharma
Official Site Inspections
http://www.cytokipharma.com
- Host name: acd89244c803f7181.awsglobalaccelerator.com
- IP address: 75.2.60.5
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Cytoki Pharma"
About Cytoki - Cytoki Pharma
Cytoki’s team of experienced executives combine deep expertise in IL-22 biology, lipidation technology and drug development to leverage the potential of IL-22 as a new treatment …See details»
Cytoki Pharma - Crunchbase Company Profile & Funding
Cytoki Pharma is a biotechnology company that specializes in developing novel medicines for diseases with a significant unmet medical need with a focus on …See details»
Contact us - Cytoki Pharma
Email. [email protected]. Headquarters. Cytoki Pharma ApS Vandtårnsvej 77 DK-2860 Søborg Denmark. Get directionsSee details»
Cytoki Pharma - LinkedIn
Cytoki Pharma is a privately held Danish clinical stage biotechnology company pioneering a new class of medicines that harness IL-22 biology to drive improved outcomes for metabolic disease and IBD.See details»
Cytoki 2025 Company Profile: Valuation, Funding
Cytoki General Information Description. Developer of novel medicines designed for subcutaneous injection for the treatment of metabolic and inflammatory diseases. The company's medicines harness the power of Interleukin-22, a …See details»
Cytoki Pharma Information - RocketReach
Cytoki Pharma is a privately held Danish clinical stage biotechnology company pioneering a new class of medicines that harness IL-22 biology to drive improved outcomes for metabolic …See details»
Cytoki Pharma | DANISH BIO – DANSK BIOTEK
Cytoki Pharma is a biotechnology company focused on serious diseases caused by epithelial injury with unmet medical need. The company was founded in 2019 after licensing of full …See details»
Cytoki Pharma - EU-Startups
Jun 14, 2021 Articles about Cytoki Pharma: February 10, 2022 10 fantastic Danish startups to keep an eye on in 2022 and beyond!; June 28, 2021 77 Top Biotechnology Startups and Companies in Denmark (2021); June 14, 2021 87 …See details»
CytoKi Pharma ApS (CytoKi Pharma ApS) - 药物管线_专利_临床试 …
The Phase 2 study will evaluate the efficacy, safety and tolerability of the company's lead lipidated IL-22 analogue, CK-0045, in patients with obesity and type 2 diabetes COPENHAGEN, …See details»
Cytoki Pharma - Products, Competitors, Financials, Employees ...
Cytoki Pharma operates as a clinical-stage biotechnology company focused on developing a new class of medicines within the healthcare sector. Use the CB Insights Platform to explore Cytoki …See details»
Cytoki Pharma Overview | SignalHire Company Profile
Cytoki Pharma is a biotechnology company that specializes in developing novel medicines for diseases with a significant unmet medical need with a focus on serious diseases caused by …See details»
CytoKi Pharma | Lundbeckfonden
CytoKi Pharma is a pre-clinical biotechnology company with focus on serious diseases caused by epithelial injury with a high medical need.See details»
CytoKi Pharma ApS - Drug pipelines, Patents, Clinical trials - Synapse
Mar 8, 2025 Please visit www.cytokipharma.com or follow us on LinkedIn for additional details. SOURCE: Cytoki Pharma. ... The statistics for drugs in the Pipeline is the current organization …See details»
CytoKi Pharma - VentureRadar
Similar Companies: Neurophth China Private Neurophth is a Chinese biotech developing gene therapeutics for ophthalmological diseases. Neurophth was founded by Prof Bin Li's team at …See details»
Cytoki Pharma raises $45million Series A financing
May 5, 2021 Cytoki Pharma is advancing a long-acting Interleukin-22 (IL-22) variant to clinical testing with initial focus on Inflammatory Bowel Disease. The lead compound is selected from …See details»
Our Science - Cytoki Pharma
Metabolic disease is a growing global health concern that leads to increased cardiometabolic risks and comorbidities. Recent innovation has fueled new treatments that effectively reduce body …See details»
CytoKi Pharma Company Insights, Tech Stack, and Competitors
Find useful insights on CytoKi Pharma’s company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at CytoKi Pharma.See details»
Cytoki Pharma Announces Positive Phase 1 Data Showing …
Cytoki Pharma, ApS (Cytoki), a clinical-stage biotechnology company pioneering a new class of medicines that harness IL-22 biology to drive improved outcomes for metabolic disease, …See details»
Cytoki Pharma - CoBee Company Profile & Funding Rounds
Cytoki Pharma is a biotechnology company that specializes in developing novel medicines for diseases with a significant unmet medical need with a focus on serious diseases caused by …See details»
U.S. FDA Grants Full Approval of VITRAKVI® (larotrectinib) for …
WHIPPANY, N.J., April 10, 2025 – Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted full approval for VITRAKVI® (larotrectinib), a first-in-class …See details»